---
category: news
title: "Artificial Intelligence for better antibody drugs: ready for prime time?"
excerpt: "The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion."
publishedDateTime: 2022-11-07T07:55:00Z
originalUrl: "https://pharmaphorum.com/views-and-analysis/artificial-intelligence-for-better-antibody-drugs-ready-for-prime-time/"
webUrl: "https://pharmaphorum.com/views-and-analysis/artificial-intelligence-for-better-antibody-drugs-ready-for-prime-time/"
type: article
quality: 36
heat: 36
published: false

provider:
  name: pharmaphorum
  domain: pharmaphorum.com

topics:
  - AI

images:
  - url: "https://pharmaphorum.com/wp-content/uploads/2022/11/artificial-intelligence-antibody.jpg"
    width: 1200
    height: 675
    isCached: true

secured: "ayAeCwAcSTMPE+Hnmi0+T33FYMAkRQ+Uv0V1ECjHMMfcF8ZJCK42unwuhJ7jhZM/hZ8Fo2PShYoqi0W1Nu/7jR8136WmPD/bzxkGKcPB3qGVuZwP3pXwhzihNm4blbeJDazN1G8If3z40Di+6EzQYVaTqW7uusWor/oFmcIWoAx/ZViQgOw9JhymYP7aKwZsfTIR3QU52LveWClb9Adae3zZe2DEpQFCujnX26Bcgb5R4h+J1r01JYVPm22FOyXJUlamPsN9zZf1tkF3acUTX/NYH3mihQFmZU4sacHFf1HhZNodkuuZ2eqoMpJWH8Gyjb3/L4njbhheAsIZaoj5n7HqmLn1eAvbdq4okt0H3xk=;Ol197SbH4QSFTHXgefT8Xw=="
---

